Skip to content

Author

Rohit Bhatia

We have 4 of 21 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Design, Synthesis, Molecular Dynamics, and In Vitro Evaluation of Isatin‐Based Quinazoline Derivatives as Potential Antidiabetic Agents

A series of substituted indolo[2,1‐b]quinazoline‐6,12‐diones (SJ1‐SJ8), which consist of already published derivatives (SJ1‐SJ5) and newly synthesized derivatives (SJ6‐SJ8), has been studied for their possible α‐amylase inhibition property as an antidiabetic lead compound. The synthesized derivatives have been identifi...

Sahil Jaidka, Ankush Kumar, Christopher Basumatary et al. · 0 citations
Review Sep 2026

Neolignans as emerging anticancer leads: Isolation, chemical diversity, structure-activity relationships.

Neolignans are potential natural product-derived anticancer leads; rational SAR-guided optimization, sophisticated delivery methods, and computational drug development may speed up their clinical translation.

Samarth Kumar, Ankush Kumar, Thakur Gurjeet Singh et al. · 0 citations
Review Open access Jul 2026

Beyond one drug–one target: AI-guided discovery of multi-target antiviral therapeutics

The theoretical framework, rationalization, and therapeutic benefits of the MTAs, and the critical issues under the pharmacokinetics, toxicity, and clinical development are discussed, and the future outlook is on AI-based precision antiviral therapeutics.

Vrinda Gupta, Sahil Sharma, Vikrant Abbot et al. · 0 citations
Review Jul 2026

Nanocarrier-based targeting strategies in epilepsy: addressing pathophysiological barriers.

Nanomedicine represents a promising approach for overcoming the limitations of conventional epilepsy therapy by enabling efficient brain-targeted drug delivery by enabling efficient brain targeting of antiepileptic drugs.

Abhishek Chauhan, Ankush Kumar, Ankit Awasthi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.